These findings suggest that WARS2+ cells are characterized by enhanced redox homeostasis, transcriptional efficiency, and mitochondrial biosynthetic programs—hallmarks of metabolically active and proliferative cancer phenotypes. This evidence concerns the gene WARS2 and cancer.